Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04927234 · ClinicalTrials.gov registry record · NA

Foot and Ankle Post-operative Oedema Management Using Geko™

A NA study of Surgery and Edema, sponsored by Firstkind.

Completed
Registry status
NA
Development phase
123
Enrollment target
5
Study locations

NCT04927234 is a NA study of Surgery and Edema that has completed, run by Firstkind. The registered enrollment target is 123 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 5 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04927234, a NA study of Surgery and Edema, has completed, sponsored by Firstkind.

COMPLETED
Registry status
NA
Development phase
123 participants
Enrollment target
5
Study locations

Study Summary

The multicentre randomised geko™ Foot and Ankle Trial will prospectively and systematically collect clinical data on patients randomised, on a 1:1 basis, to either standard care or standard care plus geko™ therapy to assess oedema management and patient outcomes during a follow-up period of up to three months post-surgery.

Conditions Studied

Interventions

  • DEVICE geko™ therapy

Study Locations (5)

Other

  • Hospital Universitario Vall d'Hebron - Barcelona
  • Hospital Clinic Barcelona - Barcelona
  • Maidstone and Tunbridge Wells NHS Trust - Royal Tunbridge Wells
  • The Royal National Orthopaedic Hospital NHS Trust - Stanmore

California

  • Golden State Orthopedics and Spine - Capitola

Trial Details

FieldValue
Enrollment Target 123 participants
Start Date 2022-10-07
Est. Completion 2024-08-05
Phase NA

Sponsor

Firstkind

3 total trials

What the Registry Record Tells You About NCT04927234

The ClinicalTrials.gov registry entry for NCT04927234 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The listed sponsor is Firstkind, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which geko™ therapy is the first listed.

NCT04927234 reports 5 study locations spanning 2 distinct geographic areas - top geographies include Other, California.

Frequently Asked Questions

What is clinical trial NCT04927234 about?

NCT04927234 is a clinical study titled "Foot and Ankle Post-operative Oedema Management Using Geko™". The multicentre randomised geko™ Foot and Ankle Trial will prospectively and systematically collect clinical data on patients randomised, on a 1:1 basis, to either standard care or standard care plus geko™ therapy to assess oedema management and patient outcomes during a follow-up period of up to th...

What is the current status of trial NCT04927234?

This trial is currently completed. It is a NA study. The enrollment target is 123 participants. The study started on 2022-10-07. Estimated completion is 2024-08-05.

What conditions does trial NCT04927234 study?

This clinical trial studies the following conditions: Surgery, Edema.

What interventions are being tested in trial NCT04927234?

The interventions under investigation include: geko™ therapy (DEVICE).

Who is sponsoring clinical trial NCT04927234?

This trial is sponsored by Firstkind, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04927234 being conducted?

This trial has 5 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.